Matches in Nanopublications for { ?s ?p "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 28 of
28
with 100 items per page.
- NP761746.RAi6l47J2zP_yw4cJOsz6OAae8mHeZ2RpbtjlaCamW1ao130_assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761746.RAi6l47J2zP_yw4cJOsz6OAae8mHeZ2RpbtjlaCamW1ao130_provenance.
- NP937612.RAd5LE8yyK3LVAe_BU7vbehSeigZ3-3dL0HhktI4lWnY4130_assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP937612.RAd5LE8yyK3LVAe_BU7vbehSeigZ3-3dL0HhktI4lWnY4130_provenance.
- NP284547.RA1iDuSN_wzrQ3zd5vpK2p_OyekW4kvWUl0G3iwCO4hrQ130_assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP284547.RA1iDuSN_wzrQ3zd5vpK2p_OyekW4kvWUl0G3iwCO4hrQ130_provenance.
- NP788281.RAoWH-q-6w1mjx87m66QgH2hZRhGmDpHDku2Jqft99RsE130_assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP788281.RAoWH-q-6w1mjx87m66QgH2hZRhGmDpHDku2Jqft99RsE130_provenance.
- assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP613759.RA8lJLS4de6K8_OASZrf7rNh42a63FcAjchdokcQReHFY130_assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP613759.RA8lJLS4de6K8_OASZrf7rNh42a63FcAjchdokcQReHFY130_provenance.
- NP410129.RAfwhWwA2yWtjGVGNceuxEp0_Bpi4MyYIX_lrHsyJUbCU130_assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410129.RAfwhWwA2yWtjGVGNceuxEp0_Bpi4MyYIX_lrHsyJUbCU130_provenance.
- NP895305.RA4dNx4e-bg_1uM4p-WijE3tPHwcBSgnZl5Asbrz3x31A130_assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP895305.RA4dNx4e-bg_1uM4p-WijE3tPHwcBSgnZl5Asbrz3x31A130_provenance.
- NP453242.RAGi6UsSUP5a2IUGSOn5veG-PlIFfskZQOa_3HctUdkjk130_assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP453242.RAGi6UsSUP5a2IUGSOn5veG-PlIFfskZQOa_3HctUdkjk130_provenance.
- assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP752647.RAFTSWMBE8t_0pbjeOC64zsxNbr07o_3AWkIoDM9CHhvE130_assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP752647.RAFTSWMBE8t_0pbjeOC64zsxNbr07o_3AWkIoDM9CHhvE130_provenance.
- NP769060.RAXdNs1v3zY7-QZl1lA6roiKYaXdRKPwvIB8xAgA2qO-c130_assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP769060.RAXdNs1v3zY7-QZl1lA6roiKYaXdRKPwvIB8xAgA2qO-c130_provenance.
- NP769065.RAZ4KLnDo0nclTRXkolZo__e5BcW0EIp-pRiiz4jHH6xk130_assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP769065.RAZ4KLnDo0nclTRXkolZo__e5BcW0EIp-pRiiz4jHH6xk130_provenance.
- NP409587.RAsKnjsIOVBTlCI2rZIpBfziS0yXdqGsT7yO2wvn8-A1U130_assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP409587.RAsKnjsIOVBTlCI2rZIpBfziS0yXdqGsT7yO2wvn8-A1U130_provenance.
- NP801745.RAvqpwxdCgXg24SBs_N8Glwng76tzGStjdQ0gwswptMCU130_assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801745.RAvqpwxdCgXg24SBs_N8Glwng76tzGStjdQ0gwswptMCU130_provenance.
- NP801763.RAtTEOIll-xCYLEiuaPlwakUSUWRBODv733R6bHVUI7k8130_assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801763.RAtTEOIll-xCYLEiuaPlwakUSUWRBODv733R6bHVUI7k8130_provenance.
- NP769063.RAoTw3KjSK363_KVYzijG5XPmL343tovZXFWks39CbClg130_assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP769063.RAoTw3KjSK363_KVYzijG5XPmL343tovZXFWks39CbClg130_provenance.
- NP409403.RAwu14bvStADVmg0VGNR1IdDF5wNdl1pTk7l7ABRJLP4c130_assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP409403.RAwu14bvStADVmg0VGNR1IdDF5wNdl1pTk7l7ABRJLP4c130_provenance.
- NP801752.RA3Ipe7YTMJkAqi3AwH4YJo_c2O5z6fH7GpA5i3u8tuMA130_assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801752.RA3Ipe7YTMJkAqi3AwH4YJo_c2O5z6fH7GpA5i3u8tuMA130_provenance.
- NP769059.RA6km_G1M4_zoWl6bmobaIRJykH9xNKcVdhFN7u90qIF8130_assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP769059.RA6km_G1M4_zoWl6bmobaIRJykH9xNKcVdhFN7u90qIF8130_provenance.
- NP769062.RA4-Ld0XI6mp5Xlp_Eh5xDhBVeQRbeSlL8S-bPwQel0O8130_assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP769062.RA4-Ld0XI6mp5Xlp_Eh5xDhBVeQRbeSlL8S-bPwQel0O8130_provenance.
- NP769064.RA7G2U7WGWXXaz0TrB9u_JZlwO1v1xXqZSDmeA42O5df4130_assertion description "[Quantitative RT-PCR analysis using human EDB-FN primers shows that subcutaneous grafting in immunodeficient mice is per se sufficient to cause a dramatic up-regulation of EDB-FN expression by these cells, as well as by human oesophageal cancer KYSE 30 cells and renal carcinoma Caki-1 cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP769064.RA7G2U7WGWXXaz0TrB9u_JZlwO1v1xXqZSDmeA42O5df4130_provenance.